Pelliciari, Davy Henrique Sousa, Caio Ricco Alves Reis, and Carlos Alberto Bordini. 2024. “Should Anti-CGRP Monoclonal Antibodies Always Be the Drug of First Choice for Migraine Prophylaxis in Brazil? - a Pharmacoeconomic Study”. Headache Medicine 15 (3):170-74. https://doi.org/10.48208/HeadacheMed.2024.34.